Monitoring of thyroid function test abnormalities in cancer patients undergoing immune checkpoint inhibitor therapy in a community based cancer center.

Sitki Copur, Mehmet; Evans, Spencer; Olsen, Jon; Schilling, Sonja; Wurdeman, Julie; Mae Obermiller, Angela; Ramaekers, Ryan; Gauchan, Dron; J. Crockett, David; Clark, Douglas; Schriner, Megan; Nelson, Deborah; M. McDonald, Monica; Kezeor, Jami; Norvell, Max

doi:10.1200/jco.2018.36.15_suppl.e15064

Public

Monitoring of thyroid function test abnormalities in cancer patients undergoing immune checkpoint inhibitor therapy in a community based cancer center.

Shared by NobleBlocks on May 20, 2018 • 12:00 AM UTC

Authors:

Mehmet Sitki Copur

Spencer Evans

Jon Olsen

Abstract

e15064 Background: Immune-checkpoint inhibitor (ICI) therapy related thyroid function test (TFT) abnormalities are not uncommon. No well-established guidelines on the type, frequency, and duration of monitoring of TFTs exist in this setting. We retrospectively evaluated the practice patterns of TFT ...

Subject

Medicine

Ipilimumab

Pembrolizumab

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!